PreprintAll rights reservedmedRxiv
Potential Cost of Multi-Cancer Detection Tests to Medicare
- 1University of Colorado
Related
- Liquid Biopsy and Multi‐Cancer Early Detection Tests for Cancer Screening: A Scoping Review
- The clinical and psychosocial consequences of genomic Multi-Cancer Detection (MCD) tests in underserved populations: a scoping review.
- Trends in detection of dementia among beneficiaries in Medicare advantage and traditional Medicare.
- What Medicare Claims Tell Us About Cancer Disparities in American Indian and Alaska Native Peoples
- Potential to improve early detection of lung cancer through expansion of focused and opportunistic screening approaches: a scoping review focusing on potential expansion of screening risk factors and adoption of artificial intelligence models.
BibTeX
@misc{scherer2026potential,
title = {{Potential Cost of Multi-Cancer Detection Tests to Medicare}},
author = {L. D. Scherer and D. D. Matlock and J. Cronin and M. Gritz},
howpublished = {medRxiv},
year = {2026},
month = aug,
doi = {10.64898/2026.08.24.26361257},
url = {https://www.medrxiv.org/content/10.64898/2026.08.24.26361257v1},
}
RIS
TY - UNPB
TI - Potential Cost of Multi-Cancer Detection Tests to Medicare
AU - L. D. Scherer
AU - D. D. Matlock
AU - J. Cronin
AU - M. Gritz
PY - 2026
DA - 2026/08/24
PB - medRxiv
DO - 10.64898/2026.08.24.26361257
UR - https://www.medrxiv.org/content/10.64898/2026.08.24.26361257v1
ER -